Nostrum Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 10

% Expired Patents = 70.0

CIPO Patents = 4

Trademarks = 1

Forward Citations = 205

Loading Chart...

3 inventors (with patents filed for the assignee):

Nirmal Mulye (9 out of 24 patents)

John S Lomans (1 out of 4 patents)

Kavita Inamdar (1 out of 3 patents)

10 patents: Sort by Forward Citations

1. 10391419 - Isolation and purification of conjugated estrogens (2019-08-27),

2. 8906419 - Pharmaceutical composition containing water soluble drug (2014-12-09),

3. 8545882 - Control release formulation containing a hydrophobic material as the sustained release agent (2013-10-01),

4. 8507000 - Controlled release formulation of erythromycin derivatives (2013-08-13),

5. 7897179 - Pharmaceutical composition containing water soluble drug (2011-03-01),

6. 7179486 - Process for preparing sustained release tablets (2007-02-20),

7. 7052706 - Control release formulation containing a hydrophobic material as the sustained release agent (2006-05-30),

8. 6946146 - Coating for a sustained release pharmaceutical composition (2005-09-20),

9. 6635680 - Controlled release pellet formulation (2003-10-21),

10. 6416786 - Sustained release tablet containing hydrocolloid and cellulose ether (2002-07-09),

Company Overview

Nostrum Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Edison, New Jersey, focused on developing and commercializing innovative therapies. The company specializes in the formulation and manufacturing of generic and branded pharmaceuticals, with a strong emphasis on complex generics and niche therapeutic areas. Nostrum is committed to addressing unmet medical needs through its research and development efforts, leveraging advanced technologies to enhance drug delivery and efficacy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#21 in Edison, NJ

#1,104 in New Jersey

#29,892 in US

#56,119 in the World

Edison, NJ, United States of America

Nostrum Pharmaceuticals, Inc.

Forward Citations = 205

3 inventors:

Nirmal Mulye (9 out of 24 patents)

John S Lomans (1 out of 4 patents)

Kavita Inamdar (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nostrum Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/nostrum-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]